Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Reciprocal Regulation Between Smad7 and Sirt1 in the Gut.

Sedda S, Franzè E, Bevivino G, Di Giovangiulio M, Rizzo A, Colantoni A, Ortenzi A, Grasso E, Giannelli M, Sica GS, Fantini MC, Monteleone G.

Front Immunol. 2018 Aug 10;9:1854. doi: 10.3389/fimmu.2018.01854. eCollection 2018.

2.

Follistatin-like protein 1 sustains colon cancer cell growth and survival.

Bevivino G, Sedda S, Franzè E, Stolfi C, Di Grazia A, Dinallo V, Caprioli F, Facciotti F, Colantoni A, Ortenzi A, Rossi P, Monteleone G.

Oncotarget. 2018 Jul 27;9(58):31278-31290. doi: 10.18632/oncotarget.25811. eCollection 2018 Jul 27.

3.

RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells.

Rizzo A, Di Giovangiulio M, Stolfi C, Franzè E, Fehling HJ, Carsetti R, Giorda E, Colantoni A, Ortenzi A, Rugge M, Mescoli C, Monteleone G, Fantini MC.

Cancer Immunol Res. 2018 Sep;6(9):1082-1092. doi: 10.1158/2326-6066.CIR-17-0698. Epub 2018 Jul 10.

PMID:
29991500
4.

Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.

Izzo R, Bevivino G, De Simone V, Sedda S, Monteleone I, Marafini I, Di Giovangiulio M, Rizzo A, Franzè E, Colantoni A, Ortenzi A, Monteleone G.

Inflamm Bowel Dis. 2018 May 18;24(6):1213-1224. doi: 10.1093/ibd/izy062.

PMID:
29668937
5.

Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.

Di Fusco D, Dinallo V, Monteleone I, Laudisi F, Marafini I, Franzè E, Di Grazia A, Dwairi R, Colantoni A, Ortenzi A, Stolfi C, Monteleone G.

Clin Sci (Lond). 2018 Jun 12;132(11):1155-1168. doi: 10.1042/CS20180167. Print 2018 Jun 15.

PMID:
29540537
6.

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue.

Franzè E, Dinallo V, Rizzo A, Di Giovangiulio M, Bevivino G, Stolfi C, Caprioli F, Colantoni A, Ortenzi A, Grazia AD, Sica G, Sileri PP, Rossi P, Monteleone G.

Oncotarget. 2017 Dec 15;9(3):3432-3445. doi: 10.18632/oncotarget.23289. eCollection 2018 Jan 9.

7.

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.

De Simone V, Bevivino G, Sedda S, Izzo R, Laudisi F, Dinallo V, Franzè E, Colantoni A, Ortenzi A, Salvatori S, Rossi P, Sica GS, Fantini MC, Stolfi C, Monteleone G.

Cell Death Dis. 2017 Mar 16;8(3):e2681. doi: 10.1038/cddis.2017.103.

8.

Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut.

Monteleone I, Zorzi F, Marafini I, Di Fusco D, Dinallo V, Caruso R, Izzo R, Franzè E, Colantoni A, Pallone F, Monteleone G.

Eur J Immunol. 2016 Apr;46(4):1047-57. doi: 10.1002/eji.201445228. Epub 2016 Feb 5.

9.

Interleukin-34 Induces Cc-chemokine Ligand 20 in Gut Epithelial Cells.

Franzè E, Marafini I, De Simone V, Monteleone I, Caprioli F, Colantoni A, Ortenzi A, Crescenzi F, Izzo R, Sica G, Sileri P, Rossi P, Pallone F, Monteleone G.

J Crohns Colitis. 2016 Jan;10(1):87-94. doi: 10.1093/ecco-jcc/jjv181. Epub 2015 Oct 8.

PMID:
26449789
10.

Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis.

De Simone V, Ronchetti G, Franzè E, Colantoni A, Ortenzi A, Fantini MC, Rizzo A, Sica GS, Sileri P, Rossi P, MacDonald TT, Pallone F, Monteleone G, Stolfi C.

Oncotarget. 2015 Apr 30;6(12):9908-23.

11.

Interleukin-34 sustains inflammatory pathways in the gut.

Franzè E, Monteleone I, Cupi ML, Mancia P, Caprioli F, Marafini I, Colantoni A, Ortenzi A, Laudisi F, Sica G, Sileri P, Pallone F, Monteleone G.

Clin Sci (Lond). 2015 Aug;129(3):271-80. doi: 10.1042/CS20150132.

PMID:
25800277
12.

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

De Simone V, Franzè E, Ronchetti G, Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald TT, Pallone F, Monteleone G, Stolfi C.

Oncogene. 2015 Jul;34(27):3493-503. doi: 10.1038/onc.2014.286. Epub 2014 Sep 1.

13.

Defective expression of scavenger receptors in celiac disease mucosa.

Cupi ML, Sarra M, De Nitto D, Franzè E, Marafini I, Monteleone I, Del Vecchio Blanco G, Paoluzi OA, Di Fusco D, Gentileschi P, Ortenzi A, Colantoni A, Pallone F, Monteleone G.

PLoS One. 2014 Jun 27;9(6):e100980. doi: 10.1371/journal.pone.0100980. eCollection 2014.

14.

Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Caruso R, Marafini I, Franzè E, Stolfi C, Zorzi F, Monteleone I, Caprioli F, Colantoni A, Sarra M, Sedda S, Biancone L, Sileri P, Sica GS, MacDonald TT, Pallone F, Monteleone G.

Mucosal Immunol. 2014 Nov;7(6):1467-79. doi: 10.1038/mi.2014.35. Epub 2014 May 21.

PMID:
24850427
15.

Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities.

Cupi ML, Sarra M, Marafini I, Monteleone I, Franzè E, Ortenzi A, Colantoni A, Sica G, Sileri P, Rosado MM, Carsetti R, MacDonald TT, Pallone F, Monteleone G.

J Immunol. 2014 Jun 15;192(12):6083-91. doi: 10.4049/jimmunol.1302238. Epub 2014 May 16.

16.

A functional role for Smad7 in sustaining colon cancer cell growth and survival.

Stolfi C, De Simone V, Colantoni A, Franzè E, Ribichini E, Fantini MC, Caruso R, Monteleone I, Sica GS, Sileri P, MacDonald TT, Pallone F, Monteleone G.

Cell Death Dis. 2014 Feb 20;5:e1073. doi: 10.1038/cddis.2014.49.

17.

Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

Franzè E, Caruso R, Stolfi C, Sarra M, Cupi ML, Caprioli F, Monteleone I, Zorzi F, De Nitto D, Colantoni A, Biancone L, Pallone F, Monteleone G.

PLoS One. 2013 Jul 26;8(7):e69839. doi: 10.1371/journal.pone.0069839. Print 2013.

18.

IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism.

Sarra M, Cupi ML, Bernardini R, Ronchetti G, Monteleone I, Ranalli M, Franzè E, Rizzo A, Colantoni A, Caprioli F, Maggioni M, Gambacurta A, Mattei M, Macdonald TT, Pallone F, Monteleone G.

Hepatology. 2013 Oct;58(4):1436-50. doi: 10.1002/hep.26446. Epub 2013 Aug 26.

PMID:
23564603
19.

High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases.

Franzè E, Caruso R, Stolfi C, Sarra M, Cupi ML, Ascolani M, Sedda S, Antenucci C, Ruffa A, Caprioli F, MacDonald TT, Pallone F, Monteleone G.

Inflamm Bowel Dis. 2013 Mar;19(3):501-11. doi: 10.1097/MIB.0b013e31828028e8.

PMID:
23429442
20.

Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.

Monteleone I, Federici M, Sarra M, Franzè E, Casagrande V, Zorzi F, Cavalera M, Rizzo A, Lauro R, Pallone F, MacDonald TT, Monteleone G.

Gastroenterology. 2012 Nov;143(5):1277-1287.e4. doi: 10.1053/j.gastro.2012.07.016. Epub 2012 Jul 20.

PMID:
22819866
21.

IL-15 positively regulates IL-21 production in celiac disease mucosa.

Sarra M, Cupi ML, Monteleone I, Franzè E, Ronchetti G, Di Sabatino A, Gentileschi P, Franceschilli L, Sileri P, Sica G, Del Vecchio Blanco G, Cretella M, Paoluzi OA, Corazza GR, Pallone F, Monteleone G.

Mucosal Immunol. 2013 Mar;6(2):244-55. doi: 10.1038/mi.2012.65. Epub 2012 Jul 11.

PMID:
22785229
22.

2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.

Stolfi C, Franzè E, Monteleone I, Caruso R, Franceschilli L, Sileri P, Sica GS, Gaspari AL, Del Vecchio Blanco G, Pallone F, Monteleone G.

Clin Sci (Lond). 2012 Sep;123(5):295-306. doi: 10.1042/CS20110556.

PMID:
22435743
23.

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.

Stolfi C, Rizzo A, Franzè E, Rotondi A, Fantini MC, Sarra M, Caruso R, Monteleone I, Sileri P, Franceschilli L, Caprioli F, Ferrero S, MacDonald TT, Pallone F, Monteleone G.

J Exp Med. 2011 Oct 24;208(11):2279-90. doi: 10.1084/jem.20111106. Epub 2011 Oct 10.

24.

2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.

Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.

Mol Cancer Ther. 2011 Oct;10(10):1969-81. doi: 10.1158/1535-7163.MCT-11-0316. Epub 2011 Aug 4.

25.

Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages.

Rizzo A, Monteleone I, Fina D, Stolfi C, Caruso R, Fantini MC, Franzè E, Schwendener R, Pallone F, Monteleone G.

Inflamm Bowel Dis. 2012 Mar;18(3):449-59. doi: 10.1002/ibd.21799. Epub 2011 Jun 17.

PMID:
21688353
26.

Interleukin-25 negatively controls pathogenic responses in the gut.

Franzè E, Rizzo A, Caruso R, Pallone F, Monteleone G.

Inflamm Allergy Drug Targets. 2011 Jun;10(3):187-91. Review.

PMID:
21428908
27.

Targeting interleukin-21 in inflammatory diseases.

Sarra M, Franzè E, Pallone F, Monteleone G.

Expert Opin Ther Targets. 2011 Jun;15(6):695-702. doi: 10.1517/14728222.2011.561319. Epub 2011 Mar 11. Review.

PMID:
21391901
28.

Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut.

Fina D, Franzè E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, Monteleone G.

Mucosal Immunol. 2011 Mar;4(2):239-44. doi: 10.1038/mi.2010.68. Epub 2010 Oct 13.

PMID:
20944558
29.

Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

Stolfi C, Caruso R, Franzè E, Sarra M, De Nitto D, Rizzo A, Pallone F, Monteleone G.

Immunology. 2011 Jan;132(1):66-77. doi: 10.1111/j.1365-2567.2010.03340.x. Epub 2010 Sep 14.

30.

Characterization of IL-17A-producing cells in celiac disease mucosa.

Monteleone I, Sarra M, Del Vecchio Blanco G, Paoluzi OA, Franzè E, Fina D, Fabrizi A, MacDonald TT, Pallone F, Monteleone G.

J Immunol. 2010 Feb 15;184(4):2211-8. doi: 10.4049/jimmunol.0901919. Epub 2010 Jan 8.

31.

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

De Nitto D, Monteleone I, Franzè E, Pallone F, Monteleone G.

World J Gastroenterol. 2009 Oct 7;15(37):4609-14. Review.

32.

Molecular basis of the potential of mesalazine to prevent colorectal cancer.

Stolfi C, Pellegrini R, Franze E, Pallone F, Monteleone G.

World J Gastroenterol. 2008 Jul 28;14(28):4434-9. Review.

Supplemental Content

Loading ...
Support Center